||||||||||Trial completion: Home Based Massage and Relaxation for Sickle Cell Pain (clinicaltrials.gov) - Feb 22, 2014 P2, N=30, Completed, Sponsor: National Center for Complementary and Alternative Medicine (NCCAM) No longer recruiting --> Completed
||||||||||fludarabine IV / Generic mfg., mycophenolate mofetil / Generic mfg., cyclosporine / Generic mfg. Trial completion: Bone Marrow Transplantation in Treating Children With Sickle Cell Disease (clinicaltrials.gov) - Feb 19, 2014 P1/2, N=50, Completed, Sponsor: Fred Hutchinson Cancer Research Center No longer recruiting --> Completed No longer recruiting --> Completed
||||||||||warfarin / Generic mfg. Trial termination: Anticoagulation For Pulmonary Hypertension in Sickle Cell Disease (clinicaltrials.gov) - Jan 5, 2014 P2, N=3, Terminated, Sponsor: University of North Carolina, Chapel Hill N=115 --> 38 Recruiting --> Terminated; Difficulty in accruing subjects
||||||||||warfarin / Generic mfg. Enrollment change: Anticoagulation For Pulmonary Hypertension in Sickle Cell Disease (clinicaltrials.gov) - Jan 5, 2014 P2, N=3, Terminated, Sponsor: University of North Carolina, Chapel Hill Recruiting --> Terminated; Difficulty in accruing subjects N=20 --> 3
||||||||||Trial termination: Nitric Oxide and Sickle Cell Pain (clinicaltrials.gov) - Dec 5, 2013 P=N/A, N=12, Terminated, Sponsor: National Institute of Nursing Research (NINR) N=25 --> 50 Recruiting --> Terminated
||||||||||Enrollment change: Nitric Oxide and Sickle Cell Pain (clinicaltrials.gov) - Dec 5, 2013 P=N/A, N=12, Terminated, Sponsor: National Institute of Nursing Research (NINR) Recruiting --> Terminated N=90 --> 12
||||||||||HQK 1001 / Viracta Therap Trial termination: Effects of HQK-1001 in Patients With Sickle Cell Disease (clinicaltrials.gov) - Nov 25, 2013 P2, N=77, Terminated, Sponsor: HemaQuest Pharmaceuticals Inc. N=90 --> 12 Active, not recruiting --> Terminated
||||||||||sildenafil / Generic mfg. Trial termination: Sildenafil for Treatment of Priapism in Men With Sickle Cell Anemia (clinicaltrials.gov) - Sep 19, 2013 P2, N=13, Terminated, Sponsor: Johns Hopkins University Not yet recruiting --> Recruiting Recruiting --> Terminated; funding was terminated
||||||||||sildenafil / Generic mfg. Enrollment change: Sildenafil for Treatment of Priapism in Men With Sickle Cell Anemia (clinicaltrials.gov) - Sep 19, 2013 P2, N=13, Terminated, Sponsor: Johns Hopkins University Recruiting --> Terminated; funding was terminated N=20 --> 13